A sell side firm has named the life science firm Illumina (ILMN) a new top pick (overweight) with a $320 price target. Let's check out the charts of ILMN to see if the charts are in gear with the fundamental story.
More from Investing
Here's How I'm Approaching the Popular TLT Treasury Bond ETF
The thing is, this ETF could break either way based on where it is at present.
Alibaba Shares Skyrocket in Hong Kong on Restructuring Plan
The company will split into six separate entities which will be run under separate management and free to list independently.
I Wouldn't Plow Ahead With Buying Deere Despite an Analyst's Thumbs Up
The technical picture of the farm equipment giant simply isn't encouraging.
Bank Regulations, Treasuries, Dwindling Trading Volumes, AMC, Amazon, Lockheed
These banking system steps would place increased drag on the velocity of money, which in turn will suppress economic growth.
3 International Stocks With Strong Dividends and Long-Term Growth Potential
There is considerable value to be found among international names at the moment.